BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3607807)

  • 1. Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
    Stephens JD; Marks C; Woodings D; Vandenburg MJ
    Cardiology; 1987; 74 Suppl 1():69-71. PubMed ID: 3607807
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
    Bödigheimer K; Nowak FG; Delius W
    Med Welt; 1981 Apr; 32(14A):543-7. PubMed ID: 7242318
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
    Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
    Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
    Page A; Larnaudie B; Pic A; Videau P; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of intravenous isosorbide dinitrate in patients of cardiac failure following acute myocardial infarction.
    Pande AK; Ambardekar SS; Kumar A; Tulpule AT; Goyal BK
    Indian Heart J; 1985; 37(6):339-42. PubMed ID: 3836934
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
    Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
    Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
    Caponnetto S; Canale C; Terrachini V; Masperone MA
    Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)].
    Miranda V; Saavedra J; Opazo JA; Stockins B; Contreras M; Lanas F
    Rev Med Chil; 1979 Aug; 107(8):721-3. PubMed ID: 545565
    [No Abstract]   [Full Text] [Related]  

  • 10. Isosorbide dinitrate oral spray in acute exacerbation of chronic congestive heart failure secondary to coronary artery disease.
    Marmor A; Schneeweiss A; Plich M; Blondheim D; Sharir T; Alpert JS
    Am J Cardiol; 1987 May; 59(12):1199-200. PubMed ID: 3578062
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
    Osamura Y; Takahashi S; Nakai K; Kimata S; Ogawa T; Hirosawa K
    Kokyu To Junkan; 1978 Jul; 26(7):677-83. PubMed ID: 674893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodynamic effects of isosorbide dinitrate (Isomack Retard capsules) in chronic heart failure].
    Stejfa M; Vítovec J; Blaha M; Roubalík P
    Vnitr Lek; 1988 Aug; 34(8):772-6. PubMed ID: 3176367
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
    Hutton I; McGhie AI; Martin W; Tweddel AC
    Cardiology; 1987; 74 Suppl 1():72-5. PubMed ID: 3607808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitrate therapy for congestive heart failure.
    Franciosa JA; Nordstrom LA; Cohn JN
    JAMA; 1978 Aug; 240(5):443-6. PubMed ID: 351232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide 5-mononitrate in the treatment of left ventricular failure following acute myocardial infarction.
    Murray RG; Gammage MD
    Cardiology; 1987; 74 Suppl 1():58-9. PubMed ID: 3607805
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
    Franchi F; Michelucci A; Morace G; Porciani MC; Fantini F
    Clin Ter; 1980 Apr; 93(1):3-20. PubMed ID: 7449331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and hemodynamic effects of an isosorbide dinitrate tape on patients with congestive heart failure--comparative study with nitroglycerin ointment].
    Inden M; Itou M; Noda E; Kawahira S; Tanimura H; Takasaki H; Morimoto Y; Nakano T; Takezawa H
    Kokyu To Junkan; 1983 Nov; 31(11):1245-50. PubMed ID: 6427869
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.
    Franciosa JA; Mikulic E; Cohn JN; Jose E; Fabie A
    Circulation; 1974 Nov; 50(5):1020-4. PubMed ID: 4609633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.